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Objective: Endovascular procedures are increasingly used in the treatment of peripheral arterial disease (PAD). Whether
this new procedural approach translates to clinical outcomes equivalent or superior to open surgical revascularization is
a subject of debate. We sought to analyze population-based rates of major amputations for PAD during a time period in
which the use of endovascular surgical procedures increased dramatically.
Methods: We used the 1996-2005 Nationwide Inpatient Sample (NIS) to analyze rates of amputations and vascular
interventions, and also to characterize the treatment of patients admitted acutely for PAD. Vascular interventions were
designated based on International Classification of Diseases (ICD) procedure codes as open bypass, endovascular
intervention, or major amputation (disarticulation at ankle or higher amputation). Population-based age-adjusted
incidence rates of treatment were calculated by combining procedure rates with census data.
Results: Our analysis included 97,000 acute admissions for PAD, 83,000 major amputations, 77,500 endovascular
procedures, and 171,000 open vascular bypass operations. Between 1996 and 2005, population-based rates of acute
admissions for PAD decreased by 4.3% per year, open procedures by 6.6% per year, and major amputations by 6.4% per
year, whereas endovascular procedures increased by 4.8% per year. Of patients acutely admitted for PAD, the likelihood
of undergoing an amputation decreased (30.2% to 21.8%), the likelihood of undergoing an open vascular procedure
decreased (34.5% to 26.3%), and the likelihood of undergoing an endovascular operation increased (12.7% to 28.3%). All
of these changes were statistically significant at P < .05.
Conclusion: The last decade has seen a significant increase in the use of endovascular procedures and a decrease in rates of
major amputation. These trends are seen both for patients admitted with acute PAD, as well as in the population in
general. While our study was not designed to demonstrate a causal relationship, our findings suggest an association
between increased application of endovascular technology and reduced rates of amputation in patients with PAD. (J Vasc
Surg 2009;49:910-7.)Endovascular interventions are an increasingly ac-
cepted means of treatment for peripheral arterial disease
(PAD). While open vascular bypass has long been the
standard of care, advances in technology and technique
allow endovascular techniques to be applied to an ever-
increasing number of patients. Lower profile delivery sys-
tems, subintimal recanalization techniques, contrast agents
with less nephrotoxicity, and a more widespread surgical
expertise have facilitated the expansion of endovascular
technology.
The existing literature has demonstrated the efficacy of
endovascular technology, as well as its shortcomings.1-8
Proponents of endovascular therapy cite the avoidance of
surgical wounds and their associated wound complications,
decreased cost, and shorter hospital courses. Potential crit-
icisms of the endovascular approach include the possibility
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910that failures jeopardize open bypass, suitability for treat-
ment of long-segment lesions, recurrence of disease, and
long-term outcomes. Furthermore, there is a lack of con-
sensus between physicians regarding whether the approach
to specific lesions from an open or endovascular approach
further obscures outcomes.9
Over the past two decades, endovascular procedures
are increasingly used in the treatment of PAD. The
impact of this new procedural approach on clinical out-
comes is a subject of debate, with particular concern for
complex lesions and long-term outcomes. Equivalency
between endovascular and open techniques has been
demonstrated in at least two randomized trials. In the
femoropopliteal artery segment, non-autogenous femo-
ral-to-above knee bypass was compared with percutane-
ous treatment of expanded polytetrafluoroethylene/nitinol
self expanding stent, with equivalency in patency and limb
salvage rates at a mean follow-up of 12months.10 The Bypass
Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)
trial followed patients randomized between surgery first and
angioplasty-first treatment strategies, with significant end-
points being amputation or death.11 After a six month fol-
low-up period, there were no differences in adjusted amputa-
tion-free survival.
Regardless of the ongoing uncertainty regarding the
relative clinical efficacy of endovascular vs. open technique,
the popularity of endovascular therapy and the proficiency of
its practitioners continue to grow. In this study, we evaluate
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treatment of PAD in the United States.
METHODS
Institutional Review. This study was considered ex-
empt from institutional review by the institutional review
board of the Health Sciences Campus of the University of
Southern California.
Data Source: Nationwide Inpatient Sample. The
Nationwide Inpatient Sample (NIS) from 1996-2005 (74
million discharge records) was used as source data regard-
ing treatment patterns for patients with PAD. Since 1988,
the NIS has constructed a dataset comprising approxi-
mately 20% of the hospital discharges within the United
States. In order to develop a sample that most accurately
represents the total universe of domestic hospitalizations,
hospitals are sampled according to specific characteristics
(strata), including geographic region, hospital ownership,
urban/rural location, and teaching status.12 Each dis-
charge in the NIS dataset, therefore represents approxi-
mately five domestic discharges. This 5:1 ratio is not constant
across the NIS sample, however. Certain combinations of
strata may be under-sampled or over-sampled due to prag-
matic considerations of sampling design. When this occurs,
the importance (weight) assigned to a specific hospitaliza-
tion may be greater or less than five. Unless specifically
stated, all data and analyses in this study are reported using
the weighting scheme included with the NIS.
Data elements for one or more key patient factors were
missing in approximately 25% of discharge records in the
NIS. Of these records, race was the missing variable in over
95% of records. Within the NIS dataset, several states (GA,
IL, KY,MN,NV,OH,OR,WV) do not report race data on
their discharge abstracts, and the majority of the records
with missing race data came from these states. In order to
avoid bias, we chose not to analyze or report race/ethnicity
data in our analyses.
From within the NIS, hospitalizations where the pa-
tient was admitted through an emergency room, or had an
admission type labeled as ‘urgent’ or ‘emergency’ were
considered acute admissions. A hospitalization was consid-
ered an acute admission for PAD if the patient was acutely
admitted and had a primary diagnosis (reason for admis-
sion) related to peripheral arterial disease (International
Classification of Disease [ICD] code 440.2x). Based on this
cohort of patients acutely admitted with PAD, we analyzed
whether specific types of vascular procedures were per-
formed. Types of procedures were identified as open vas-
cular bypass, endovascular bypass, and major amputation
based on ICD procedure codes (Table I). Within the NIS,
it is impossible to track patients across hospitalizations (eg,
readmissions). The dataset also does not specify which
side(s) an amputation or revascularization was performed.
In order to minimize bias related to the possibility of
registering multiple amputations on the same patient (as
noted by Rucker-Whitaker et al),13 we chose to consider
only major amputation (disarticulation of ankle or greater).
Each major amputation was classified according to thepresence or absence of specific indication(s) for undergoing
the procedure. These indications included PAD,
non-atherosclerotic PAD, infectious etiologies, malig-
nancy, and trauma. The ICD codes used to classify each
amputation are listed in Table II. Many amputations had
multiple potential indications; in these situations no at-
tempt was made to identify which indication was the pri-
mary indication, and ‘credit’ was given in each pertinent
category.
In a second, related analysis we sought to analyze
population-based rates of the use of any one of these three
types of procedures for peripheral arterial disease. We tab-
ulated numbers of open bypass, endovascular, and major
amputation procedures only if the hospitalization within
which the procedure was performed had an associated
diagnosis code of PAD (ICD code 440.2x). We also ana-
lyzed rates of acute admission according to the specific
PAD diagnosis (ICD code 440.20, 440.21, 440.22,
440.23, 440.24) that was associated with the hospitaliza-
tion.
A Charlson score was computed based on diagnosis
codes present in the hospitalization abstract according to
methods previously described.14 As the patients in our
sample, by definition, had at least one comorbidity (vascu-
lar insufficiency), this element of the comorbidity scoring
was eliminated from the computed Charlson score.
Data Source: Census Data
We obtained historical and projected population data
Table I. Description of ICD-9 procedure codes used to
search the Nationwide Inpatient Sample database
Description
ICD-9
procedure code(s)
Open vascular bypass procedures
Incision/exclusion/occlusion of aorta,
abdominal arteries, lower limb
arteries 38.14, 38.16, 38.18
Resection of lower limb artery,
replacement 38.48
Aorto-iliac-femoral bypass 39.25
Other peripheral shunt/bypass 39.29
Other revision of vascular procedure 39.49
Repair of blood vessel with synthetic
patch graft 39.57
Endovascular procedures
Angioplasty or atherectomy of non-
coronary vessel 39.50
Insertion of non-coronary artery stent
or stents 39.90
Major amputation procedures
Disarticulation of ankle 84.13
Amputation of ankle through malleoli
of tibia and fibula 84.14
Other amputation below knee 84.15
Disarticulation of knee 84.16
Amputation above knee 84.17
ICD, International Classification of Diseases.through the U.S. Census Bureau.15 Census data were used
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age-specific and age-adjusted incidence rates.
Analytic Methods: Computation of Incidence Rates
Age-adjusted incidence rates were calculated within
four age groups: 18 to 44, 45-64, 65-74, and 75 years and
older. For the purposes of reporting changes in
age-adjusted incidence rates, incidence rates were standard-
ized to the 1996 population.
Analytic Methods: Computation of Annual Percent
Change
Temporal trends were analyzed by computing esti-
mated annual percent change (EAPC). EAPC was calcu-
lated by fitting a linear regression to the log transformation
of the outcome variable of interest (procedure rates).16
Calendar year is then considered the predictor variable of
interest, and a P value of  .05 indicates a statistically
significant (nonzero) slope. The parameter estimate for
calendar year can then be transformed to yield EAPC. This
technique allows for significance testing as well as quantifi-
cation of temporal changes in the rates of outcome vari-
ables.
Analytic Methods: Software
Database manipulation was performed using Visual
Table II. Description of ICD-9 diagnosis codes
Description
ICD-9
diagnosis code(s)
Atherosclerotic peripheral arterial
disease
Atherosclerosis of the extremities,
unspecified 440.20
Atherosclerosis of the extremities
with intermittent claudication 440.21
Atherosclerosis of the extremities
with rest pain 440.22
Atherosclerosis of the extremities
with ulceration 440.23
Atherosclerosis of the extremities
with gangrene 440.24
Non-atherosclerotic peripheral vascular
disease
Other peripheral vascular disease 443.xx
Arterial embolism and thrombosis,
lower extremity 444.22
Malignancy
Malignant neoplasm of bone and
articular cartilage 170.xx
Malignant neoplasm of connective
and other soft tissue 171.xx
Malignant melanoma of skin 172.xx
Trauma (presence of any E-code)
Infectious
Septicemia 38.xx
Osteomyelitis, periostitis, and
other infections involving bone 730.xx
Gangrene 785.4x
ICD, International Classification of Diseases.Foxpro version 9.0 (Microsoft Inc, Redmond, Wash). Sta-tistical analyses were conducted with SAS version 9.1.3
(SAS Institute Inc, Cary, NC). Because the NIS is a strati-
fied probability sample of US community hospitals, we
adjusted our calculations for survey sampling characteris-
tics.
RESULTS
A total of 97,081 acute admissions for PAD, 171,587
open vascular procedures, 76,460 endovascular proce-
dures, and 83,298 major amputations were analyzed (un-
weighted number of hospitalizations). The profile of pa-
tients experiencing each of these types of therapy is detailed
in Table II.
Population-Based Rates of Treatment
The characteristics of patients in our study that were
admitted acutely with PAD, underwent open vs. endovas-
cular bypass, or had a major amputation are reported in
Table III.
Rates of Acute Admissions for PAD. Patients that
were admitted acutely with PAD were 72.1 years of age,
and slightly more often male than female (Table III).
Population-adjusted rates of admissions declined steadily
over the course of the 10-year study period, from 2.5 to 1.9
per 10,000 population (Fig 1). This corresponds to an
estimated annual percent change of -4.3% per year (P 
.05).
Rates of Open vs. Endovascular Bypass Procedures.
The characteristics of patients undergoing endovascular
and vascular procedures for PAD during any admission
(acute or non-acute admissions), are displayed in Table II.
Overall, patients undergoing endovascular procedures were
quite similar to those undergoing open bypass procedures,
in terms of age and gender distribution. Patients that
underwent open vascular bypass procedures between 1996
and 2005 had an average age of 68.5 and 72.1 years,
respectively, and were more commonly male. The fre-
quency of open vs. endovascular bypass procedures
changed dramatically over the 10-year study period. In
1996, open vascular procedures outnumbered endovascu-
lar procedures by approximately 3 to 1. By 2005, they were
almost similar in frequency.
Rates of Major Amputations. Individuals undergo-
ing major amputation were older (72.2 years) than those
that had open or endovascular procedures performed. The
number of major amputations fell significantly between
1996 and 2005, by an estimated 6.4% per year (P  .05)
(Fig 1, Table II). Rates of decrease were more dramatic in
the 75 age group than in the younger age groups (Fig 2).
We also analyzed population-based rates of major am-
putation by diagnosis (PAD, non-atheroslerotic PVD, in-
fection, malignancy, trauma, and other/unspecified). The
specific ICD diagnosis codes used to assign the indica-
tion(s) for the procedure are in Table I; results of this
analysis are displayed in Fig 3. The vast majority of the
reduction in population-based rates of major lower extrem-
ity amputations is due to decreases in amputation rates for
PAD.
al art
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Admission for PAD
The types of procedures performed on a patient admit-
ted acutely for PAD changed significantly over the 10-year
period of our study (Fig 4). In 1996, such an admission was
30.2% likely to result in a major amputation; by 2005 this
likelihood decreased to 21.9%. The likelihood of an endo-
vascular procedure more than doubled, from 12.7% in
1996 to 28.3% in 2005. The use of open vascular bypass
procedures steadily declined during acute admissions for
Table III. Patient demographics from hospitalizations, in
endovascular procedures, open procedures and major amp
Acute admissions
for PAD
Annual admissions* 48,293
Age (mean  standard deviation) 72.1  27.9
Gender
Male 52.2%
Female 47.8%
Missing 0.01%
Primary payer (patients 18-64 years old)
Private insurance 38.3%
Medicare 34.5%
Medicaid 18.6%
Other 8.6%
Missing 0.03%
Charlson score
0 28.0%
1 14.5%
2 26.4%
3 31.1%
Absolute change in volume** 8,381
Estimated annual percent change 4.3%
PAD, peripheral arterial disease.
All figures are based on weighted numbers of hospitalizations.
*Average, 1996-2005.
**Comparing 2005 to 1996.
Fig 1. Population-based rates of treatment for peripherPAD, decreasing in likelihood from 34.5% to 26.3%.DISCUSSION
This study evaluates trends in the hospital-based treat-
ment of peripheral arterial disease in the United States over
an 11-year period from 1996 to 2005. Over the last two
decades, numerous reports and anecdotal reviews by indi-
vidual surgeons attest to the increased use of endovascular
procedures for PAD.17-19 Our study is novel in that we
document a national trend in the growth of endovascular
procedures, and a parallel decrease in the population-based
rates of major amputations and open revascularization pro-
ng acute admissions for peripheral arterial disease,
ns
Open vascular bypass
procedures
Endovascular
procedures
Major
amputations
85,197 37,960 41,275
68.5  25.0 69.1  24.8 72.2  28.0
57.6% 54.7% 53.2%
42.4% 45.3% 46.8%
0.01% 0.01% 0.01%
54.8% 53.6% 28.1%
25.1% 27.0% 46.9%
13.0% 12.0% 18.9%
7.1% 7.3% 6.1%
0.02% 0.03% 0.02%
38.5% 38.7% 15.9%
11.8% 11.9% 11.4%
27.9% 26.7% 28.5%
21.8% 22.6% 44.2%
29,780 23,639 17,274
6.6% 4.8% 6.4%
erial disease in the United States from 1996 to 2005.cludi
utatiocedures for PAD.
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endovascular technology relative to rates of amputation.
Early in the endovascular era in the United States, Tunis et
al analyzed the treatment of PAD in Maryland from 1979
to 1989.20 They found increases the rates of both endovas-
cular and open revascularization procedures, but no
changes rates of amputation. Similar investigations from
countries outside the United States such as England, Den-
mark, and Canada also observed increases in endovascular
and open procedures, but varying changes in amputation
rates during the same reporting time period.21-25 In 1997
Hallet et al published a dramatic study, documenting a 50%
Fig 2. Rates of major amputation for peripheral arterial d
incidence rate reflects population-adjusted incidence ra
(adjusted to 1996 population).
Fig 3. Rates of major amputation by indication in t
population-adjusted to 1996.reduction in amputation rates over a twenty year (1973 to1993) period in Olmstead County, Minnesota.26 How-
ever, this study was limited due to its confined geographical
area and a relatively homogenous population base, as well
as the presence of a dominant tertiary hospital system.
Later in the endovascular era, Feinglass et al and the
Dartmouth group published reports based on nationally-
representative data.27,28 The Feinglass report covered a
seventeen year period (1979-1996) while the Dartmouth
Atlas a three year period (1993-1996). These reports ob-
served increases in open and endovascular procedures, but
had differing conclusions regarding changes in rates of
amputations. The study by Feinglass et al showed no
e by age in theUnited States from 1996 to 2005. Overall
ong individuals aged 18 years in the United States
nited States from 1996 to 2005. Incidence rates areiseas
te amhe Uchange, while the Dartmouth Atlas showed a mild de-
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vanced into the growth phase of endovascular technology.17,25
Similar to our report, Nowygrod and associates utilized the
NIS and other data sources to document an increase in
endovascular procedures combined with a decrease in open
revascularization surgery and a decrease in amputation rates
from 1998 to 2003.17
Theoretically, the decrease in amputation rates ob-
served by Nowygrod and ourselves may correlate to a time
period where the benefits of endovascular surgical proce-
dures positively impacted the outcomes of patients with
PAD. One possible factor for observing the improved out-
comes at this time is the rapid improvements in endovascu-
lar technology. Guidewires and ballons have smaller pro-
files, stent options now include drug elution and prosthetic
graft covering, and new generation thrombolytic agents are
available. It is possible that such technological advances
may have contributed to the improved outcomes, as dem-
onstrated by decreased amputation rates during our study
time period. A study by Hynes and associates supports this
theory.29 These investigators evaluated the influence of
implementing subintimal angioplasty into their care of
patients with critical limb ischemia. Analysis of patients
treated before and after the introduction of subintimal
angioplasty as their first line therapy in patients with Trans-
atlantic Inter-Society Consensus C andD iliac and femoro/
popliteal lesions was performed. Compared with the earlier
treatment group, overall limb salvage increased signifi-
cantly from 42% to 70% (P  .001). Improved endovascu-
lar technology, however, is certainly not the only possible
factor responsible for the observed improvement in ampu-
tation rates. Advances in medical therapy such as the ex-
panded role of statin agents and the development of more
aggressive antiplatelet drugs, as well as decreased smoking
prevalence may also have contributed to the decreased rates
Fig 4. Procedures performed during the acute admissio
to 2005.of amputation described in this report.30-33 Also, our re-port does not account for the widespread improvements in
PAD screening programs. The impact of population-based
efforts to increase PAD awareness should not be ignored.
While providers of many different types perform endo-
vascular procedures, the role of the vascular surgeon in
driving shifts in treatment patterns may have special impor-
tance. In 2002, Sullivan and associates reviewed the effect
of implementation of endovascular procedures performed
by vascular surgeons on an established surgical practice.19
Over a four-year period, endovascular procedures increased
324% accompanied with a reduction in the proportion of
open/standard to endovascular cases to 88% to 77%. Sim-
ilarly, Solomon et al reported a 679.5% increase in endovas-
cular procedures and a 47% decrease in open index vascular
cases during a five-year study period of an urban vascular
surgery practice.18 It is obvious that the commitment to
matriculating endo-competent vascular trainees by accred-
ited training programs speaks to the paradigm shift of vascular
surgery to be more involved in the total care of the vascular
patient, including both open and especially endovascular
procedures. Interventional cardiologists have also become
more involved in peripheral interventions for PAD, thus
accentuating the proliferation of endovascular procedures
in relation to open surgical procedures. Interestingly, the
most dramatic decrease in amputation rates was observed in
the elderly population (Fig 2). It may appear obvious due
to the fact that PAD is more prevalent in the aged popula-
tion, however, this finding may represent a bias by the
practitioner to extend endovascular treatments to elderly
patients whom in prior years, would not have been candi-
dates for open procedures. Unfortunately, a clear delinea-
tion of these aforementioned factors is not possible based
on our dataset.
Our study has several important limitations, largely
arising from the use of a large, population-based dataset.
eripheral arterial disease in the United States from 1996n for pFirst, we were only able to examine hospital-based care that
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We therefore we were restricted to using admissions, and
not procedures or patients, as the observation of interest. A
second limitation is that our data source only reliably
captures inpatient procedures, and may therefore not com-
pletely capture all outpatient procedures performed for
PAD. We were therefore not able to account for secular
trends that might have resulted in procedures shifting from
inpatient to outpatient environments. With the rise in
specialty outpatient surgical centers and effective arterial
closure devices, endovascular interventions are safely per-
formed without the need for overnight observation.34,35
For this same reason, the rise in endovascular procedures in
our decade of interest may actually be underestimated.
Also, any shift resulting in a higher threshold of care would
result in a population of patients that is increasingly clini-
cally severe, and possibly an underestimation of a shift in
treatment away from amputation. We found that even
given this secular trend that major amputations are per-
formed less often and minimally invasive interventions are
more common. While our analyses cannot prove that en-
dovascular technology is the root cause of these improve-
ments in amputation rates, the circumstantial evidence for a
causal link is strong.
Further confounding the analysis is lack of categoriza-
tion of the patients’ disease processes. Simple lesions might
be preferentially treated by practitioners with endovascular
therapy. Choice of revascularization method might also be
influenced by the systemic health of individual patients.
Although the Charlson score between open and endovas-
cular treatment groups remains equivalent, this could re-
flect a balancing phenomenon from treating the simplest
lesions and the most complex lesions in patients deemed
unsuitable risk for open surgery.
In conclusion, we find that between 1996 and 2005 the
practices patterns applied to the treatment of patients with
PAD in the United States underwent a significant shift.
Based on a nationally-representative, population-based data
source we saw a significant increase in the use of endovas-
cular procedures and a decrease in rates of major amputa-
tion. These trends are seen both for patients admitted with
acute PAD, as well as in the population in general. Whether
this represents a direct cause and effect phenomenon is not
certain based on this study, but our findings suggest an
association between increased application of endovascular
technology and reduced rates of amputation in patients
with PAD. The reason for these trends is unclear, but
should remain a matter of ongoing investigation.
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